Target intelligence / Profile preview

Bacterial and viral antigens and toxins

Molecular classification
Protein, Polysaccharide, Lipopolysaccharide, Glycoprotein, Exotoxin, Endotoxin, Other
01

Overview

Bacterial and viral antigens and toxins represent a broad class of pathogen-derived molecules that are central to the pathogenesis of infectious diseases and serve as the primary targets for vaccines and immunotherapies. Antigens are typically proteins, polysaccharides, or lipids that are recognized by the host's immune system, such as the spike protein of viruses or the cell wall components of bacteria (National Institute of Allergy and Infectious Diseases, 2023). Toxins are specialized proteins or lipopolysaccharides (e.g., exotoxins and endotoxins) secreted or released by bacteria to damage host cells or suppress the immune response (StatPearls, 2023). These molecules facilitate host cell attachment, entry, and the subversion of cellular processes to favor pathogen replication. Therapeutic strategies targeting these molecules include vaccines that induce long-term memory, monoclonal antibodies that neutralize viral entry or toxin activity, and antitoxins for immediate treatment of toxemia (CDC, 2022). Because this group includes thousands of distinct molecular entities, drug development is highly specific to the individual pathogen and its unique virulence factors. Understanding the structural biology of these antigens and toxins is essential for designing effective countermeasures against infectious diseases (Nature Reviews Microbiology, 2021).

Other names
Pathogen-derived antigensMicrobial toxinsViral proteinsBacterial virulence factorsImmunogens
02

Mechanism of action

Neutralization of viral entry, neutralization of bacterial exotoxins, opsonization for phagocytosis, complement activation, and induction of active immunity via vaccination.

03

Biological functions

PathogenesisHost cell attachmentImmune evasionCellular toxicitySignal transduction modulation
04

Disease associations

InfectionSepsisToxemiaRespiratory distressInflammation
05

Safety considerations

Antibody-dependent enhancement (ADE)Hypersensitivity and anaphylaxisSerum sicknessAntigenic drift and escape mutationsOff-target immune activation
06

Interacting drugs

Bezlotoxumab

9 more in the full profile.

07

Biomarkers

Serum antibody titers (IgG/IgM)Pathogen load (viral/bacterial DNA/RNA)T-cell activation markersC-reactive protein (CRP)Procalcitonin

Beyond the preview

Go deeper on Bacterial and viral antigens and toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and viral antigens and toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call